Video Experimental Relacionado
Updated: Jan 13, 2026

09:06
Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice
Published on: February 20, 2019
8.8K
Enfoques Transcriptómicos Integrativos y Bioinformáticos Combinados con Modelos Transformer Identifican Redes
Dongdong Yan1, Wenqiang Li2, Erkun Xing1
1Department of Cardiology, The First Hospital of Lanzhou University, Lanzhou, Gansu, China.
Resumen
Este estudio identifica TYROBP y TNF como genes clave en la progresión de la aterosclerosis utilizando aprendizaje profundo y bioinformática. Estos hallazgos resaltan un eje inmunoinflamatorio y posibles dianas terapéuticas para la aterosclerosis.
Conclusiones:
- La aterosclerosis implica un eje inmunoinflamatorio que suprime la identidad del músculo liso.
- TYROBP y TNF son biomarcadores candidatos prometedores y dianas terapéuticas para la aterosclerosis.
Palabras clave:
interpretabilidad SHAPTYROBPTabTransformeraterosclerosisgenes centrales inmunitariosvalidación de LDL oxidadobiomarcadores predictivosdesdiferenciación de músculo lisoMás Videos Relacionados
Videos de Conceptos Relacionados
Atherosclerosis I: Introduction
868
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
868
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
452
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
452
Atherosclerosis III: Management
311
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
311

